New treatment in breast cancer metastatic and pretreated

被引：0
作者：
Di Cristina, L
Cirrito, D
Vitello, S
机构：
[1] Serv Oncol, Alcamo, TP, Italy
[2] Osped S Elia Caltanissetta, Serv Oncol, Caltanissetta, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E26
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
[11]   AMINOGLUTETHIMID IN THE THERAPY OF THE PRETREATED METASTATIC BREAST-CANCER [J].
KOHLER, AH .
ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1989, 44 (23) :2053-2055
[12]   Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer [J].
Bartsch, Rupert ;
Wenzel, Catharina ;
Altorjai, Gabriela ;
Pluschnig, Ursula ;
Rudas, Margaretha ;
Mader, Robert M. ;
Gnant, Michael ;
Zielinski, Christoph C. ;
Steger, Guenther G. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3853-3858
[13]   What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer? [J].
Verma, S ;
Trudeau, M ;
Dranitsaris, G ;
Clemons, M ;
Joy, AA ;
MacKey, JR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6260-6260
[14]   Treatment strategies for patients with anthracycline- and taxane-pretreated metastatic breast cancer [J].
Seidman, Andrew D. .
SEMINARS IN ONCOLOGY, 2008, 35 (02) :A3-A4
[15]   Ixabepilone, a New Treatment Option for Metastatic Breast Cancer [J].
Toppmeyer, Deborah L. ;
Goodin, Susan .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (05) :516-521
[16]   Ixabepilone: A new antimitotic for the treatment of metastatic breast cancer [J].
Bhushan, Shriya ;
Walko, Christine M. .
ANNALS OF PHARMACOTHERAPY, 2008, 42 (09) :1252-1261
[17]   Fulvestrant in heavily pretreated metastatic breast cancer: Is it still effective as a very advanced line of treatment? [J].
Safra, Tamar ;
Greenberg, Julia ;
Ron, Ilan G. ;
Ben-Yosef, Rami ;
Inbar, Moshe ;
Sarid, David ;
Yaal-Hahoshen, Neora .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (05) :339-343
[18]   Herceptin in single and combined treatment modalities in pretreated patients with metastatic breast cancer: the Dutch experience [J].
Klijn, J ;
Schornagel, J ;
Bos, M ;
Voest, E ;
van der Wall, E ;
Muller, E ;
Hupperets, P ;
Wils, J ;
Molendijk, W ;
Bontenbal, M .
EUROPEAN JOURNAL OF CANCER, 2002, 38 :S69-S69
[19]   Thalidomide is inactive in heavily pretreated patients with metastatic breast cancer [J].
Morabito, A ;
Carillio, G ;
Longo, R ;
Gasparini, G .
CANCER JOURNAL, 2005, 11 (03) :248-251
[20]   Gemcitabine plus cisplatin in pretreated metastatic breast cancer. [J].
Moura, G. L. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345